Baseline 6-min walk distance predicts survival in lung transplant candidates

被引:66
作者
Martinu, T. [1 ]
Babyak, M. A. [2 ]
O'Connell, C. F. [2 ]
Carney, R. M. [3 ]
Trulock, E. P. [4 ]
Davis, R. D. [5 ]
Blumenthal, J. A. [2 ]
Palmer, S. M. [1 ]
机构
[1] Duke Univ, Med Ctr, Div Pulm & Crit Care Med, Durham, NC 27706 USA
[2] Duke Univ, Med Ctr, Dept Psychiat, Durham, NC 27710 USA
[3] Washington Univ, Dept Psychiat, St Louis, MO USA
[4] Washington Univ, Div Pulm & Crit Care Med, St Louis, MO USA
[5] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA
关键词
exercise capacity; exercise testing; lung; lung transplantation; posttransplantation; pretransplant; prognosis; prognostic factors survival; survival analysis;
D O I
10.1111/j.1600-6143.2008.02264.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
In a large, prospectively followed, two-center cohort of patients listed for lung transplantation (n = 376), we used Cox proportional hazards models to determine the importance of baseline 6-min walk distance (6MWD) in predicting patient survival. 6MWD used as a continuous variable was a significant predictor of survival after adjusting for other important covariates when transplant was considered as a time-varying covariate (HR for each 500 ft increase in 6MWD = 0.57, 95% CI: 0.43-0.77, p = 0.0002). 6MWD remained an important predictor of survival in models that considered only survival to transplant (HR for each 500 ft increase in 6MWD = 0.41, 95% CI: 0.27-0.62, p < 0.0001) or survival only after transplant (HR for each 500 ft increase in 6MWD = 0.40, 95% CI: 0.22-0.72, p = 0.002). Unadjusted Kaplan-Meier analysis demonstrates significantly different survival by 6MWD tertiles (< 900, 900-1200, or > 1200 ft, p-value = 0.0001). In the overall model, 6MWD prediction of survival was relatively homogeneous across disease category (6MWD by disease interaction term, p-value = 0.63). Our results demonstrate a significant relationship between baseline 6MWD and survival among patients listed for lung transplantation that exists across all native disease categories and extends through transplantation. The 6MWD is thus a useful measure of both urgency and utility among patients awaiting lung transplantation.
引用
收藏
页码:1498 / 1505
页数:8
相关论文
共 24 条
[1]   DANGERS OF USING OPTIMAL CUTPOINTS IN THE EVALUATION OF PROGNOSTIC FACTORS [J].
ALTMAN, DG ;
LAUSEN, B ;
SAUERBREI, W ;
SCHUMACHER, M .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (11) :829-835
[2]   A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension [J].
Barst, RJ ;
Rubin, LJ ;
Long, WA ;
McGoon, MD ;
Rich, S ;
Badesch, DB ;
Groves, BM ;
Tapson, VF ;
Bourge, RC ;
Brundage, BH ;
Koerner, SK ;
Langleben, D ;
Keller, CA ;
Murali, S ;
Uretsky, BF ;
Clayton, LM ;
Jobsis, MM ;
Blackburn, SD ;
Shortino, D ;
Crow, JW .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (05) :296-301
[3]   Telephone-based coping skills training for patients awaiting lung transplantation [J].
Blumenthal, James A. ;
Babyak, Michael A. ;
Carney, Robert M. ;
Keefe, Francis J. ;
Davis, R. Duane ;
LaCaille, Rick A. ;
Parekh, Priti I. ;
Freedland, Kenneth E. ;
Trulock, Elbert ;
Palmer, Scott M. .
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 2006, 74 (03) :535-544
[4]   The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease [J].
Celli, BR ;
Cote, CG ;
Marin, JM ;
Casanova, C ;
de Oca, MM ;
Mendez, RA ;
Pinto Plata, V ;
Cabral, HJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (10) :1005-1012
[5]   Assessment of survival benefit after lung transplantation by patient diagnosis [J].
Charman, SC ;
Sharples, LD ;
McNeil, KD ;
Wallwork, J .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2002, 21 (02) :226-232
[6]   ATS statement: Guidelines for the six-minute walk test [J].
Crapo, RO ;
Casaburi, R ;
Coates, AL ;
Enright, PL ;
MacIntyre, NR ;
McKay, RT ;
Johnson, D ;
Wanger, JS ;
Zeballos, RJ ;
Bittner, V ;
Mottram, C .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (01) :111-117
[7]  
CRAPO RO, 1981, AM REV RESPIR DIS, V123, P659
[8]   Listing for lung transplantation: Life expectancy and transplant effect, stratified by type of end-stage lung disease, the eurotransplant experience [J].
De Meester, J ;
Smits, JMA ;
Persijn, GG ;
Haverich, A .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2001, 20 (05) :518-524
[9]   Lung function tests in patients with idiopathic pulmonary fibrosis - Are they helpful for predicting outcome? [J].
Erbes, R ;
Schaberg, T ;
Loddenkemper, R .
CHEST, 1997, 111 (01) :51-57
[10]   Idiopathic pulmonary fibrosis - Prognostic value of changes in physiology and six-minute-walk test [J].
Flaherty, Kevin R. ;
Andrei, Adin-Cristian ;
Murray, Susan ;
Fraley, Chris ;
Colby, Thomas V. ;
Travis, William D. ;
Lama, Vibha ;
Kazerooni, Ella A. ;
Gross, Barry H. ;
Toews, Galen B. ;
Martinez, Fernando J. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 174 (07) :803-809